Canada Corporation Registry
Back to the company page
Canada Corporation RegistryCorporate profile report
Prepared
Nov 16, 2026
Corporation number
9657754

Fairhaven Pharmaceuticals Inc.

ActiveFederal corporation under the Canada Business Corporations Act

Fairhaven Pharmaceuticals Inc. is an active federal corporation (corporation number 9657754). Its business number is 755959483. It was incorporated on May 4, 2018 under the Canada Business Corporations Act and its registered office is in Belleville, Ontario. Its annual returns are up to date, most recently for 2026. It has two directors on record.

Corporation

Corporation number
9657754
Business number
755959483
Status
Active
Governing law
Canada Business Corporations Act
Incorporated
May 4, 2018
Number of directors
At least 1, at most 10
Corporation type
Non-distributing corporation with 50 or fewer shareholders
Registered office
231 Dundas St E
Belleville ON K8N 1E2

Annual filings

Anniversary date
May 4
Annual filing period
May 4 to Jul 3
Last annual meeting
Jun 18, 2026
Last annual return filed
2026
Year202620252024
Annual returnFiledFiledFiled

The last annual return filed, and each year since.

Directors (2)

NameAddress for service
Eugene Nelson Siklos65 Queen St W
Suite 2400
Toronto ON M5H 2M8
Bruce Pritchard3rd Floor
1 Ashley Road
Altrincham, Cheshire WA142DT

As listed on the federal record on Nov 9, 2026. A director may give an address for service instead of a home address.

Names, filings and certificates

NameFormIn use since
Fairhaven Pharmaceuticals Inc.NameJul 3, 2018
WhatDate
Articles amendedDec 16, 2024
IncorporatedMay 4, 2018

About this report

Prepared by Canada Corporation Registry on Nov 16, 2026 from the federal corporations data as it stood that day and the corporation's federal record as last read. It is not an official record or a certificate of compliance. Check the federal record before relying on it: ised-isde.canada.ca/cc/lgcy/fdrlCrpDtls.html?corpId=9657754

Contains information licensed under the Open Government Licence – Canada.